EN / 中文

SensingX Unveils 64-channel Closed-loop BCI Chip and 1024-channel Ultra-low-power Wireless Acquisition Chip

by xiangzhi·November 17, 2026

Brain-computer interfaces (BCIs) remained confined to the research level in the 1970s, later finding application in serious medical neural modulation, and in recent years rapidly expanding into education, scientific research, national defense, and even consumer electronics. "Currently, human communication with the outside world relies primarily on smartphones; BCIs are viewed as the next-generation terminal—faster, smaller, and more convenient." The industry truly gained momentum around 2020 when Elon Musk's company completed brain-control experiments on macaques and performed the first human implantation in January 2024, bringing BCIs into the public spotlight. Statistics show that patients in the United States, the United Kingdom, and Canada have undergone BCI implants, totaling 27 cases so far. Domestically, progress is also underway, with Borui Kang obtaining China's first Class III clinical certification for a brain-computer interface. At the 5th Nandujiang Smart Healthcare and Rehabilitation Industry Summit Forum held on November 13, Yin Ming, founder of SensingX (Hainan) Co., Ltd. and professor at Hainan University, introduced the company's relevant products and latest developments regarding the currently most watched BCI chips.

In Yin Ming's view, one of the core technologies of BCIs is the chip, stating that "chips define the functions and parameter metrics of brain-computer interfaces." The current state of the industry presents mixed prospects: China's "15th Five-Year Plan" has included BCIs among six key future industries, and Hainan's "15th Five-Year Plan" has also incorporated them into the future industrial direction within its "45432" strategic framework; the action plan for brain-computer interfaces jointly issued by seven ministries explicitly calls for breakthroughs in critical chip technologies.

However, the upstream segment of the industrial chain remains notably thin—the proportion of upstream enterprises is only 8%, with even fewer companies manufacturing chips. More pressing issues include reliance on imported signal acquisition chips, restrictions on the sale of stimulation modulation chips to China, and the lack of mature solutions for wireless transmission. SensingX targets precisely these shortcomings. Since the first half of last year, the company has successively launched high-throughput neural recording chips, high-degree-of-freedom neural modulation chips, and ultra-low-power wireless transmission chips, with a clear direction: independent R&D and domestic substitution. Yin Ming highlighted two specific chips from the company.

The first is a closed-loop acquisition-stimulation chip, now iterated to the fourth generation. It features 64 channels, each integrating both acquisition and stimulation modules, enabling closed-loop switching between acquisition and stimulation in situ with a switching speed of less than 0.5 milliseconds. Yin Ming explained the significance of this metric: for a closed-loop BCI to function effectively, the interval between acquisition and stimulation must be sufficiently short to form feedback similar to that of natural nervous systems, thereby leveraging neuroplasticity to aid in the rehabilitation of damaged nerves. Previously, regulation for spinal cord injuries was open-loop, with only electrodes above the injury plane providing continuous stimulation; with this chip, bridging across the spinal cord plane can be achieved. The chip has been validated in mice using Utah electrode arrays, with a stimulation current of 100 microamperes and a pulse width of 200 microseconds, demonstrating measured inter-channel switching control within 0.5 milliseconds.

The second is a future-oriented thousand-channel integrated acquisition-transmission chip featuring 1024 acquisition channels capable of transmitting raw data completely. Small size and low power consumption are its selling points—with wireless transmission included, power consumption is only 18 milliamperes, currently the lowest globally. It has entered the beta testing phase and is being trialed by downstream application partners. The chip also includes essential electrode impedance testing functions required for implantable scenarios, supporting three communication modes: single-wire, infrared, and conventional wireless. The infrared link automatically pauses when obstructed, and manual switching between wired and wireless modes is supported.

In terms of industrialization, SensingX's BCI chips currently serve over 40 clients, including leading domestic enterprises and institutions. The company's scientific research support comes from Hainan University: the university has established a macaque validation platform, with a BCI platform spanning 100,000 square meters of research space, comprising 16 teams, and equipped with a clinical transformation hospital, capable of simultaneously supporting applied research and preclinical validation.